Filing Details

Accession Number:
0001209191-15-014941
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-17 20:46:12
Reporting Period:
2015-02-13
Filing Date:
2015-02-17
Accepted Time:
2015-02-17 20:46:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDNQ Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1596060 Seth Andrew Sandler 1301 2Nd Ave
Seattle WA 98101
Evp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-02-13 7,791 $0.09 313,839 No 4 S Direct
Common Stock Disposition 2015-02-13 105,925 $0.09 207,914 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Open market sale